Erythropoietin Slows Photoreceptor Cell Death in a Mouse Model of Autosomal Dominant Retinitis Pigmentosa

Autor: Kristi Wynn, Wesley S. Bond, Tonia S. Rex, Lorraine Kasmala, Alfred S. Lewin, Ana M. de Lucas Cerrillo
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Retinal degeneration
Photoreceptors
Sensory Receptors
genetic structures
Vision
lcsh:Medicine
Social Sciences
Photoreceptor cell
Mice
0302 clinical medicine
Animal Cells
Medicine and Health Sciences
Psychology
lcsh:Science
Neurons
Multidisciplinary
Gene therapy of the human retina
biology
Cell Death
Retinal Degeneration
Gene Transfer Techniques
Anatomy
Animal Models
Dependovirus
3. Good health
medicine.anatomical_structure
Rhodopsin
Cell Processes
Retinal Cone Photoreceptor Cells
Retinal Disorders
Sensory Perception
Cellular Types
Retinitis Pigmentosa
Research Article
Signal Transduction
Ocular Anatomy
Mouse Models
Gene delivery
Research and Analysis Methods
Retina
03 medical and health sciences
Gene Delivery
Model Organisms
Ocular System
Retinitis pigmentosa
medicine
Gene Expression and Vector Techniques
Animals
Humans
Point Mutation
Outer nuclear layer
Molecular Biology Techniques
Molecular Biology
Erythropoietin
Vision
Ocular

Molecular Biology Assays and Analysis Techniques
Opsins
lcsh:R
Retinitis
Biology and Life Sciences
Afferent Neurons
Cell Biology
Genetic Therapy
medicine.disease
Molecular biology
Ophthalmology
Disease Models
Animal

030104 developmental biology
Cellular Neuroscience
030221 ophthalmology & optometry
biology.protein
lcsh:Q
sense organs
Neuroscience
Zdroj: PLoS ONE
PLoS ONE, Vol 11, Iss 6, p e0157411 (2016)
ISSN: 1932-6203
Popis: Purpose To test the efficacy of systemic gene delivery of a mutant form of erythropoietin (EPO-R76E) that has attenuated erythropoietic activity, in a mouse model of autosomal dominant retinitis pigmentosa. Methods Ten-day old mice carrying one copy of human rhodopsin with the P23H mutation and both copies of wild-type mouse rhodopsin (hP23H RHO+/-,mRHO+/+) were injected into the quadriceps with recombinant adeno-associated virus (rAAV) carrying either enhanced green fluorescent protein (eGFP) or EpoR76E. Visual function (electroretinogram) and retina structure (optical coherence tomography, histology, and immunohistochemistry) were assessed at 7 and 12 months of age. Results The outer nuclear layer thickness decreased over time at a slower rate in rAAV.EpoR76E treated as compared to the rAAV.eGFP injected mice. There was a statistically significant preservation of the electroretinogram at 7, but not 12 months of age. Conclusions Systemic EPO-R76E slows death of the photoreceptors and vision loss in hP23H RHO+/-,mRHO+/+ mice. Treatment with EPO-R76E may widen the therapeutic window for retinal degeneration patients by increasing the number of viable cells. Future studies might investigate if co-treatment with EPO-R76E and gene replacement therapy is more effective than gene replacement therapy alone.
Databáze: OpenAIRE